{
  "@context": "aku-v2",
  "@type": "procedure",
  "@id": "wsmg:health-sciences/medicine/nephrology/neph-047",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:53:50.000Z",
    "modified": "2026-01-13T14:30:00.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "quality-agent"
    ],
    "confidence": 0.96,
    "status": "validated",
    "language": "en",
    "licenses": ["CC-BY-4.0"]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/nephrology",
    "subdomain": "diagnostic_procedures",
    "type": "procedure",
    "difficulty": "intermediate",
    "importance": "high",
    "isNativeDomain": true,
    "board_yield": "HIGH"
  },
  "content": {
    "title": "Hematuria Evaluation",
    "summary": "Hematuria (blood in urine) requires systematic evaluation to distinguish glomerular from non-glomerular sources and identify underlying pathology. The workup differs based on microscopic vs gross hematuria, patient age, and risk factors for malignancy. Key diagnostic steps include urinalysis with microscopy, imaging, and cystoscopy when indicated.",
    "key_points": [
      "Microscopic hematuria: ≥3 RBCs/HPF on two separate UA specimens",
      "Gross hematuria always warrants full urologic evaluation regardless of age",
      "Dysmorphic RBCs and RBC casts indicate glomerular origin",
      "Isomorphic RBCs suggest urologic (non-glomerular) source",
      "Cystoscopy recommended for patients ≥35 years or with risk factors",
      "CT urography is preferred imaging for hematuria workup"
    ],
    "statement": "Hematuria evaluation is a systematic approach to identifying the source and etiology of blood in urine, differentiating glomerular from urologic causes, and guiding appropriate diagnostic workup including imaging and cystoscopy based on patient risk stratification.",
    "explanation": {
      "intuition": "Think of hematuria as a red flag that could indicate problems anywhere along the urinary tract - from glomeruli to urethra. Like a detective, you must trace the source: glomerular bleeding gives distorted (dysmorphic) RBCs after passing through the basement membrane, while urologic bleeding yields normal-looking (isomorphic) cells.",
      "key_insight": "The critical distinction is glomerular vs non-glomerular hematuria. Glomerular sources (dysmorphic RBCs, casts, proteinuria) point to nephrology workup, while non-glomerular sources (isomorphic RBCs, clots) require urologic evaluation including imaging and cystoscopy to rule out malignancy.",
      "technical_details": "Dysmorphic RBCs show membrane blebs, budding, and irregular shapes due to osmotic stress traversing the glomerular basement membrane. The AUA defines microscopic hematuria as ≥3 RBCs/HPF. Risk factors for malignancy include age ≥35, smoking, gross hematuria, irritative voiding symptoms, and chemical exposures."
    },
    "definitions_glossary": {
      "hematuria": "Presence of blood in urine; microscopic (≥3 RBCs/HPF) or gross (visible)",
      "microscopic_hematuria": "≥3 RBCs per high-power field on urinalysis microscopy",
      "gross_hematuria": "Visible blood in urine; always requires full evaluation",
      "dysmorphic_RBCs": "Abnormally shaped RBCs indicating glomerular origin with membrane distortion",
      "isomorphic_RBCs": "Normal-appearing RBCs suggesting non-glomerular (urologic) source",
      "RBC_cast": "Cylindrical structure containing RBCs; pathognomonic for glomerular bleeding",
      "cystoscopy": "Direct visualization of bladder interior using endoscope",
      "CT_urography": "CT imaging with IV contrast optimized for urinary tract evaluation",
      "phase_contrast_microscopy": "Technique to identify dysmorphic RBCs with enhanced morphologic detail",
      "acanthocyte": "Specific dysmorphic RBC with ring shape and membrane projections; G1 cells",
      "myoglobinuria": "Myoglobin in urine mimicking hematuria; dipstick positive but no RBCs",
      "hemoglobinuria": "Free hemoglobin in urine mimicking hematuria; no RBCs on microscopy",
      "pyuria": "White blood cells in urine; may accompany hematuria in UTI"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "mechanism": "Blood enters urine from disruption of vascular integrity at any level of the urinary tract",
      "sources": {
        "glomerular": {
          "mechanism": "RBCs traverse damaged glomerular basement membrane, becoming dysmorphic",
          "causes": ["IgA nephropathy", "Thin basement membrane disease", "Alport syndrome", "Post-infectious GN", "Lupus nephritis"],
          "findings": ["Dysmorphic RBCs (>80%)", "RBC casts", "Proteinuria >500mg/day", "Acanthocytes (G1 cells)"]
        },
        "non_glomerular_upper_tract": {
          "mechanism": "Bleeding from kidney parenchyma, renal pelvis, or ureter",
          "causes": ["Renal cell carcinoma", "Transitional cell carcinoma", "Nephrolithiasis", "PKD", "Renal infarction", "Papillary necrosis"],
          "findings": ["Isomorphic RBCs", "Blood clots (vermiform if ureteral)", "Flank pain"]
        },
        "non_glomerular_lower_tract": {
          "mechanism": "Bleeding from bladder, prostate, or urethra",
          "causes": ["Bladder cancer", "BPH", "Prostatitis", "UTI", "Urethral trauma", "Radiation cystitis"],
          "findings": ["Isomorphic RBCs", "Terminal hematuria", "Dysuria", "Clots"]
        }
      }
    },
    "diagnostic_criteria": {
      "AUA_definition": "≥3 RBCs/HPF on properly collected urinalysis; confirm on repeat if initial positive",
      "risk_stratification": {
        "low_risk": {
          "criteria": ["Age <40", "Never smoker", "≤10 RBCs/HPF", "No gross hematuria", "No risk factors"],
          "recommendation": "Repeat UA in 6 months; shared decision-making for cystoscopy"
        },
        "intermediate_risk": {
          "criteria": ["Age 40-59", "10-30 pack-year smoking", "11-25 RBCs/HPF", "One prior episode"],
          "recommendation": "Cystoscopy and renal ultrasound (or CT urography)"
        },
        "high_risk": {
          "criteria": ["Age ≥60", ">30 pack-years", ">25 RBCs/HPF", "Gross hematuria"],
          "recommendation": "Cystoscopy and CT urography required"
        }
      },
      "essential_workup": [
        "Urinalysis with microscopy (centrifuged specimen)",
        "Urine culture if pyuria present",
        "Serum creatinine and BUN",
        "Urine protein:creatinine ratio",
        "Phase-contrast microscopy if available"
      ]
    },
    "differential_diagnosis": [
      "True hematuria: glomerular vs non-glomerular",
      "Pseudohematuria: hemoglobinuria, myoglobinuria",
      "Pigmenturia: beets, rifampin, phenazopyridine",
      "Menstrual contamination",
      "Exercise-induced hematuria (benign, transient)"
    ],
    "treatment_options": {
      "general_approach": [
        "Complete diagnostic workup before treatment",
        "Treat underlying cause identified",
        "Nephrology referral for glomerular hematuria",
        "Urology referral for non-glomerular hematuria"
      ],
      "by_etiology": {
        "glomerulonephritis": "Immunosuppression per specific diagnosis; ACE-I/ARB for proteinuria",
        "nephrolithiasis": "Hydration, analgesia, intervention for obstructing stones",
        "bladder_cancer": "TURBT, intravesical therapy, or cystectomy per staging",
        "UTI": "Appropriate antibiotics with repeat UA after treatment"
      },
      "observation_criteria": [
        "Exercise-induced hematuria: repeat UA after 72h rest",
        "Benign familial hematuria: annual monitoring",
        "Isolated microscopic hematuria with negative workup: annual UA"
      ]
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Hematuria Evaluation"
    },
    "altLabel": [
      {"@language": "en", "@value": "Haematuria workup"},
      {"@language": "en", "@value": "Blood in urine evaluation"},
      {"@language": "en", "@value": "Hematuria assessment"},
      {"@language": "en", "@value": "Microscopic hematuria evaluation"}
    ],
    "definition": {
      "@language": "en",
      "@value": "A systematic diagnostic approach to identify the source and etiology of hematuria, distinguishing glomerular from non-glomerular causes through urinalysis, imaging, and cystoscopy"
    },
    "notation": "neph-047",
    "scopeNote": {
      "@language": "en",
      "@value": "Covers diagnostic evaluation of both microscopic and gross hematuria in adults, including risk stratification and referral criteria"
    }
  },
  "relationships": {
    "skos:broader": [
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/diagnostic-procedures",
        "skos:prefLabel": "Nephrology Diagnostic Procedures"
      }
    ],
    "skos:narrower": [
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/glomerular-hematuria",
        "skos:prefLabel": "Glomerular Hematuria Workup"
      }
    ],
    "skos:related": [
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/neph-046",
        "skos:prefLabel": "Proteinuria Evaluation"
      },
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/neph-045",
        "skos:prefLabel": "Urinalysis Interpretation"
      },
      {
        "@id": "wsmg:health-sciences/medicine/urology/cystoscopy",
        "skos:prefLabel": "Cystoscopy"
      }
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Hematuria"
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "281588004",
      "uri": "http://snomed.info/id/281588004",
      "description": "Hematuria evaluation"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "R31.9",
      "uri": "http://hl7.org/fhir/sid/icd-10-cm/R31.9",
      "description": "Hematuria, unspecified"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D006417",
      "uri": "http://id.nlm.nih.gov/mesh/D006417",
      "description": "Hematuria"
    }
  ],
  "pedagogical": {
    "learning_objectives": [
      "Define microscopic and gross hematuria using AUA criteria",
      "Distinguish glomerular from non-glomerular hematuria by RBC morphology",
      "Apply risk stratification to determine appropriate workup intensity",
      "Identify indications for cystoscopy and CT urography",
      "Recognize red flags requiring urgent urologic evaluation"
    ],
    "clinical_pearls": [
      ">80% dysmorphic RBCs or acanthocytes >5% = glomerular source",
      "RBC casts are pathognomonic for glomerular bleeding",
      "Dipstick positive but no RBCs = myoglobinuria or hemoglobinuria",
      "Gross hematuria ALWAYS needs full workup regardless of age",
      "Anticoagulation does not cause hematuria - still evaluate",
      "Post-menopausal women and men >50 with any hematuria: think malignancy"
    ],
    "board_yield": "HIGH",
    "estimated_time": "20min",
    "target_audience": [
      "medical_students",
      "internal_medicine_residents",
      "family_medicine_physicians",
      "nephrology_fellows"
    ],
    "common_misconceptions": [
      "Anticoagulants explain hematuria - they unmask lesions, not cause bleeding",
      "Exercise hematuria is always benign - still need follow-up to confirm resolution",
      "Only gross hematuria needs workup - microscopic hematuria can indicate malignancy"
    ]
  },
  "prerequisites": [
    {
      "@id": "wsmg:health-sciences/medicine/nephrology/neph-045",
      "skos:prefLabel": "Urinalysis Interpretation"
    }
  ],
  "related_concepts": [
    "urinalysis",
    "cystoscopy",
    "CT urography",
    "glomerulonephritis",
    "bladder cancer screening"
  ],
  "evidence": {
    "citations": [
      {
        "authors": "Barocas DA, Boorjian SA, Alvarez RD, et al.",
        "title": "Microhematuria: AUA/SUFU Guideline",
        "journal": "J Urol",
        "year": 2020,
        "volume": "204",
        "pages": "778-786",
        "doi": "10.1097/JU.0000000000001297"
      },
      {
        "authors": "Yun EJ, Meng MV, Carroll PR",
        "title": "Evaluation of the patient with hematuria",
        "journal": "Med Clin North Am",
        "year": 2004,
        "volume": "88",
        "pages": "329-343",
        "doi": "10.1016/S0025-7125(03)00172-X"
      }
    ],
    "confidence_rationale": "Based on AUA/SUFU 2020 guidelines for microhematuria evaluation"
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-13T14:30:00.000Z",
    "sources": [
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill, 2022.",
        "type": "textbook",
        "year": 2022,
        "isbn": "978-1264268504",
        "relevance": "Standard internal medicine reference"
      },
      {
        "source": "AUA/SUFU Microhematuria Guideline 2020",
        "type": "clinical_guideline",
        "year": 2020,
        "relevance": "Current evidence-based recommendations"
      }
    ]
  },
  "quality_assessment": {
    "content_quality_score": 0.94,
    "completeness": 0.95,
    "accuracy": 0.96,
    "clarity": 0.93,
    "clinical_relevance": 0.95,
    "last_assessed": "2026-01-13T14:30:00.000Z"
  },
  "owl:sameAs": "http://dbpedia.org/resource/Hematuria",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q217195"
}